Ungeremine acetate is primarily studied for its potential therapeutic applications, particularly in the field of neuroscience and oncology. Research indicates that it exhibits acetylcholinesterase inhibitory activity, making it a candidate for the treatment of neurodegenerative diseases such as Alzheimer's. By inhibiting this enzyme, it may help increase acetylcholine levels in the brain, potentially improving cognitive function and memory in patients. Additionally, its cytotoxic properties have been explored in cancer research, where it shows promise in inducing apoptosis in certain cancer cell lines, suggesting its potential as an anticancer agent. Further studies are ongoing to fully understand its efficacy and safety in these applications.